KCT0004406已完成未知
A human study to evaluate of efficacy and safety of Euglena gracilis powder on immune function
Daesang0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 70(Year)（—）
- 性别
- All
入选标准
- •1) Subject who voluntarily agrees to participate and signs in informed consent form
- •2) Healthy people, 20 = age < 70.
- •3) Stress self assessment scaled above strong
- •4) Subjects suffered from upper respiratory track infection or cold-related symptoms which have possibilities to cause upper respiratory track infection more than two times in the past one year.
- •5) white blood cell(WBC) ranged from 4X10000 to 10X1000cells/ul.
排除标准
- •1) Patients who was diagnosed and are currently in the treatment of diabetes
- •2) Subjects who are currently in the treatment of significant clinical disease related to acute or chronic cardiovascular system, immune system, respiratory system, liver biliary, kidney and urinary tract, nervous system, musculoskeletal disorders, psychic, infection and blood neoplastic.
- •3) Subjects who have medical history with myocardial infarction or cerebrovascular diseasey within 6 months.
- •4) Subjects who have a neurologically or psychologically important medial history or who is currently suffering from a disease.
- •5) Subjects who have uncontrolled high blood pressure.
- •6) Subjects whose AST or ALT exceeds 3 times of normal range.
- •7) Subjects whose creatinine exceeds exceeds 2 times of normal range.
- •8) Subjects who have complained of severe gastrointestinal symptoms such as heartburn, indigestion.
- •9) Subjects who got a vaccination within 3months before screening.
- •10) Subjects whose BMI is under 18.5 or exceeds 30.0
- •11) Subjects who continue to consume beta-glucan or algae-containing food within one month of their first visit
- •12) Subjects who have intaken or is intaking functional foods
- •13) Subjects who are planning to participate other studies within one month of their first visit
- •14) Subjects who are pregnant or breastfeeding or planning a pregnancy.
- •15) Subjects who are sensitive to test foods/algae or have food allergies.
- •16) Subjects who are deemed to be inappropriate to this study.
研究者
相似试验
已完成
不适用
A human study to evaluate of efficacy and safety of EFR on immune functioKCT0006255Bundang Jesaeng Hospital100
已完成
不适用
A human study to evaluate the efficacy and safety of extracts of Ficus erecta var. sieboldii King Leaves on arthritis : a randomized, double-blind, placebo-controlled studyDiseases of the musculo-skeletal system and connective tissueKCT0002613Jeju Technopark60
已完成
不适用
A human study to evaluate the efficacy and safety of CKDHC-P29 in men with lower urinary tract symptomsKCT0004585Seoul Metropolitan Government Seoul National University Boramae Medical Center80
招募中
不适用
A human study to evaluate the efficacy and safety of rice bran extract on climacteric symptoms in perimenopausal and postmenopausal womeKCT0003282S&D60
已完成
Unknown
A human study to evaluate the efficacy and safety of the extract of Cornus alba L. for prostate healthKCT0008316Seoul Metropolitan Government Seoul National University Boramae Medical Center10